Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 885
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
for
Neuroblastoma
Location: Aurora CO, Fort Worth TX, Dallas TX, Los Angeles CA,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium
Sex: All
Age: 1 - 31
Code: NCT06450041
Phase 2, Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
for
GRIN-related Neurodevelopmental Disorder
Location: Aurora CO, Dallas TX, Iowa City IA, Austin TX,
Sponsor: GRIN Therapeutics, Inc.
Sex: All
Age: 0 - 18
Code: NCT07224581
Phase 3, Recruiting
Minima Stent System Post- Approval Study (PAS)
for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Aurora CO, Dallas TX, Austin TX, Saint Louis MI,
Sponsor: Renata Medical
Sex: All
Age: 0+
Code: NCT06828770
Recruiting
Non-invasive Prediction of EArly Cardiac rEjection
Location: Denver CO, Little Rock AR, St Louis MO, San Diego CA,
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 6 - 25
Code: NCT07770659
Recruiting
Optimal Ventilation for Cardiac Arrest
for
Cardiac Arrest (CA)
Location: Denver CO, Dallas TX, Iowa City IA, Austin TX,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 18
Code: NCT07114510
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
for
Recessive Dystrophic Epidermolysis Bullosa
Location: Aurora CO, Chicago IL, Galveston TX, Palo Alto CA
Sponsor: Abeona Therapeutics, Inc
Sex: All
Age: 0+
Code: NCT07700966
Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Aurora CO, Albuquerque NM, Omaha NE, El Paso TX,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Aurora CO, Salt Lake City UT, Sioux Falls SD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07630974
Phase 1, Phase 2, Recruiting
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
for
Pneumococcal Disease
Location: Aurora CO, West Jordan UT, Layton UT, Provo UT,
Sponsor: Pfizer
Sex: All
Age: 1 - 17
Code: NCT07660198
Phase 3, Recruiting
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
for
Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL
Location: Aurora CO, Fort Worth TX, Houston TX, Indianapolis IN,
Sponsor: Allterum Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07586618
Phase 1, Recruiting
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Location: Denver CO, Phoenix AZ, Dallas TX, Los Angeles CA,
Sponsor: David Chu
Sex: All
Age: 5+
Code: NCT07390318
Recruiting
Childhood Cancer Survivor Study
for
Cancer
Location: Aurora CO, Fort Worth TX, Minneapolis MN, St Louis MO,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT01120353
Recruiting
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
for
Eosinophilic Esophagitis (EoE)
Location: Aurora CO, Phoenix AZ, Fort Worth TX, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 0 - 6
Code: NCT07112378
Phase 3, Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Aurora CO, Salt Lake City UT, Sioux Falls SD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT06941272
Phase 1, Phase 2, Recruiting
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
for
Cystic Fibrosis (CF)
Location: Aurora CO, Plano TX, Orange CA, Bloomington IN,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 1 - 11
Code: NCT07048574
Recruiting
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
for
Thrombocytopenia, Neonatal Alloimmune
Location: Aurora CO, Salt Lake City UT, Iowa City IA,
Sponsor: Janssen Research & Development, LLC
Sex: Female
Age: 18 - 45
Code: NCT06533098
Phase 3, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Aurora CO, Albuquerque NM, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
for
Chronic Rhinosinusitis Without Nasal Polyps
Location: Aurora CO, Colorado Springs CO, Salt Lake City UT,